medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Evaluating the impact of non-pharmaceutical interventions for SARS-CoV-2 on a global scale
Rachel Esra1,2*, Lise Jamieson2*, Matthew P. Fox2,3, Daniel Letswalo2, Nkosinathi Ngcobo2, Sithabile
Mngadi2, Janne Estill1, Gesine Meyer-Rath2,3, Olivia Keiser1
*Corresponding author, rachel.esra@unige.ch
1
Division of Infectious Diseases and Mathematical Modelling, Institute of Global Health, Faculty of
medicine; University of Geneva, Geneva, Switzerland,
2
Health Economics and Epidemiology Research Office (HE2RO), Department of Medicine, Faculty of
Health Sciences, University of the Witwatersrand, Johannesburg, South Africa,
3
Department of Global Health, Boston University School of Public Health, Boston, Massachusetts,
United States of America
Abstract
In the absence of a viable pharmaceutical intervention for SARS-CoV-2, governments have implemented
a range of non-pharmaceutical interventions (NPIs) to curb the spread of infection of the virus and the
disease caused by the virus, now known as COVID-19. Given the associated social and economic costs, it
is critical to enumerate the individual impacts of NPIs to aid in decision-making moving forward. We used
globally reported SARS-CoV-2 cases to fit a Bayesian model framework to estimate transmission
associated with NPIs in 26 countries and 34 US states. Using a mixed effects model with country level
random effects, we compared the relative impact of other NPIs to national-level household confinement
measures and evaluated the impact of NPIs on the global trajectory of the COVID-19 pandemic over time.
We observed heterogeneous impacts of the easing of restrictions and estimated an overall reduction in
infection of 23% (95% CI: 18-27%) associated with household confinement, 10% (95% CI: 1-18%) with
limits on gatherings, 12% (95% CI: 5-19%) with school closures and 17% (95% CI: 6-28%) with mask
policies. We estimated a 12% (95% CI: 9-15%) reduction in transmission associated with NPIs overall. The
implementation of NPIs have substantially reduced acceleration of COVID-19. At this early time point,
we cannot determine the impact of the easing of restrictions and there is a need for continual assessment of
context specific effectiveness of NPIs as more data become available.
Author contributions: R.E., L.J. and G.M. conceptualised this research, R.E. conducted data analysis and
visualization, R.E., D.L, N.N. and S.M compiled the intervention timeline, R.E. wrote the original draft,
L.J., G.M., M. F., J.E. and O.K. reviewed and edited the final draft.
Competing interest: The author(s) declare no competing interests.
Data availability: Code and data used for this analysis are open source and can be found here:
https://gitlab.com/igh-idmm-public/covid-19/covid19_npi_globalrt_estimations
Role of the funding source: Rachel Esra is supported in part by the European Union‚Äôs Horizon 2020
research and innovation programme and the Swiss Excellence Foreign Scholar Grant. Olivia Keiser is
supported by the Swiss National Science Foundation Grants 163878 and 196270.This study has additionally
been made possible by the generous support of the American People and the President‚Äôs Emergency Plan
for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreement 72067419CA00004
to HE2RO. The contents are the responsibility of the authors and do not necessarily reflect the views of
PEPFAR, USAID or the United States Government.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Introduction
The novel SARS-CoV-2 virus was identified in late December 2019 with first cases occurring in Wuhan
City, Hubei Province, China. A rapid spread of the virus in China, followed by an exponential increase of
global cases of the virus, resulted in the declaration of a global pandemic by the World Health Organization
(WHO) on March 11, 2020. As of the end of July 2020, reported infections have exceeded 13 million
representing a small fraction of the estimated global burden and resulting in almost than 580 000 reported
deaths1. Transmission of SARS-CoV-2 occurs via droplets or direct contact2. Mortality associated with
the disease cause by the virus, now known as COVID-19, is highest in those of older age and those with
pre-existing vascular and respiratory conditions 2.
In the absence of viable pharmaceutical interventions, governments have implemented non-pharmaceutical
interventions (NPIs) informed by historical outbreaks of H1N1 Influenza 3, severe acute respiratory
syndrome (SARS) and Middle East Respiratory Syndrome (MERS)4. Using data from control measures
implemented in China in the first months of the epidemic 5,6, mathematical modelling studies 7‚Äì10, and,
observational evidence 11, NPIs have been implemented at both national and sub-national scales, at varying
times in the epidemic trajectory and at varying levels of severity. These interventions have ranged from the
closure of educational institutions, social distancing measures, restrictions on public gatherings, face-mask
policies and, enforcement of large-scale quarantines including stay-at-home orders, household
confinements and national lockdowns. NPIs have been implemented to reduce population contact and slow
down transmission rates resulting in an estimated 55% of the total global population observing some form
of self-quarantine by the end of April 2020 12.
Through the implementation of NPIs, a number of Asian and European countries first affected by the
pandemic have curbed infection rates and have achieved epidemic control 8. As infection rates continue to
rise in other regions, a number of European countries have begun to lift restrictions starting May 2020. A
recent study utilised the incidence rate ratio, the ratio of the rate of new infections reported between two
time-periods, to evaluate the impact of NPIs in 139 countries 11. They reported that physical distancing
measures were associated with a 13% reduction of SARS-CoV-2 incidence. One of the difficulties in
enumerating the quantitative impact of COVID-19 NPIs relates to the currently available measurement of
transmission based on real-time reported SARS-CoV-2 incidence. Discrepancies in the coverage and
strategy of testing over time, as well as delays in reporting and time to symptom onset, mean that dailyconfirmed cases do not give an accurate depiction of the total infected population at a given point in time.
Due to this, a number of groups have implemented dynamic mathematical modelling to estimate
transmission parameters that are currently unknown 7‚Äì10. A recent systematic review of evidence until
March 12 2020 included observational and modelling studies of SARS and MERS outbreaks and modelling
studies of COVID-19 related NPIs, concluding that quarantine measures were effective in reducing
transmission and COVID-19 related deaths4. Authors cautioned that data from SARs and MERS outbreaks
may not be applicable to the current pandemic and that results from modelling studies were based on limited
data at this early stage4.
The European Centre of Disease Prevention and Control (ECDC) developed an age-stratified dynamic
transmission model to estimate the impact of NPIs in 30 European countries from the start of the pandemic
to 2 May 20209. In the absence of empirical evidence on the efficacy of SARS-CoV-2 related NPIs, they
used expert opinion to estimate and rank the effectiveness of enforced lockdowns, voluntary home
confinement, and closure of public spaces and cancellation of mass gatherings estimating an 70% median
reduction in population contacts as a result of NPI implementation9. Using a semi-mechanistic Bayesian
hierarchical model, Flaxman et al. estimated the impact of lockdowns, banning of public events, school
closures, self-isolation and social distancing in eleven European countries from the start of the pandemic to

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

May 4, 20208. Due to the close and often overlapping time-periods in which interventions were
implemented in the early stages of the pandemic, they were unable to ascertain the impacts of specific
interventions. They did however estimate that periods of national lockdowns have led to an 81% (95% CI:
75-87%) reduction in transmission overall, as well as the prevention of 3.1 million deaths across all eleven
countries 8. Another study [currently in preprint] utilised a Susceptible-Infected-Recovered (SIR) model
with time-varying covariates for nine countries in three continents that were or currently are SARS-CoV-2
epicentres10. They found that travel restrictions and social distancing were not associated with reductions
in transmission and instead ascertained that a combination of school closures, mask wearing and centralized
quarantine may be sufficient to replace full lockdown measures10. Since the publication of these studies, a
number of research organisations have begun to collate and validate global datasets tracking the
implementation of SARS-CoV-2 NPIs by either assigning a time varying ordinal scale of the severity of
interventions implemented or using a variety of intervention categorisation frameworks13.
To our knowledge, no-one has implemented Bayesian methodology accounting for uncertainty in SARSCoV-2 transmission and data reporting, to quantify the impact of specific related NPIs across all global
regions. Additionally, we incorporated the first global estimates of the impacts of easing of restrictions up
to May 31st, 2020. Previous studies have focused on European countries first affected by the pandemic and
as such the effectiveness of NPIs in other global regions where cases continue to rise is currently unknown.
It is critical to enumerate the individual impacts of NPIs to aid in decision making moving forward,
especially for countries in the second and third wave of affected countries. We consider the impact of the
timing of the interventions in the local trajectory of the pandemic. In addition to what is currently known
about the impact of NPIs in European countries in the first months of the pandemic, we include countries
affected later in the global trajectory, where we expect a different impact of specific NPIs as global
awareness has resulted in large-scale behavioural changes.
Methods
Global NPI timeline: We created a global timeline of the implementation on NPIs including quarantine
and isolation policies, limits on gatherings, school closures (primary, secondary and tertiary educational
institutions), mask policies, household confinements (stay-at-home-orders, shelter in place orders and
lockdowns) and the easing of restrictions. We included all countries and United States (US) where COVID19 had exceeded 5000 cases by May 31st, 2020. We accessed daily reported cases from the United States
Centers for Disease Control (CDC) COVID Data Tracker14 for the US and European Centre of Disease
Prevention and Control data for the rest of the world, all accessed on May 31st, 20201. We utilised the public
health and social measures global dataset curated by the WHO (WHO PHSM), a consolidated dataset of
six global databases of COVID-19 related public health and social measures13. A full description of our
validation of the dataset is detailed in the Supplementary materials. We additionally included information
NPI implementation in the US from the Boston University School of Public Health US state policy database
15
. We included only compulsory NPIs implemented on a national (or state-level in US) scale and validated
timelines by cross-referencing dates with official governmental and health ministry announcements. A full
description of the timeline, sources and collection methodology can be found in the supplementary material.
In line with methodology used in previous publications8,9, we assumed the effect of household confinement
to supersede the effect of any other NPI implemented simultaneously and excluded any interventions
implemented after household confinement and prior to easing of restrictions. We defined the start date of
an intervention as the date on which the intervention was implemented and the end date as the date of any
successive intervention in the timeline. Based on the assumption of a 5-day latency period for SARS-CoV216, we included all events that had been implemented for a minimum of 5 days in the absence of any other
event. For interventions that are currently ongoing and where no successive interventions have been
implemented, we defined the end date as the date on which the analysis was conducted (May 31st, 2020).
We defined the date of easing of restrictions as the date at which any of the following was officially

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

announced: lifting of household confinement orders, opening of schools, opening of non-essential industry
activities and easing of limitations on gatherings.

Estimation and comparison of intervention specific Rt: We utilised the EpiNow R package, developed
by Abbot et al., to estimate the time varying daily reproduction numbers, Rt, from daily reported cases while
accounting for uncertainty in reporting delays, incubation period and generation time17. A full description
of the package and specifications used to propagate uncertainty are described in full elsewhere17. Following
the methodology described, a publicly available line-list of reported cases and time to symptom onset was
used to estimate uncertainty in the delay between symptom onset and case notification 18. We estimated
exponential and gamma distributions of time to symptom onsets for each confirmed case and binomial
upscaling was used to account for right truncation of notification dates. This same methodology was used
to estimate uncertainty in the serial interval. Assuming a normal distribution, parameters were sampled
from the reporting delay distribution and serial interval distribution were generated as described elsewhere
17
. Generation time was estimated as described by Ganyani et al.19 using an incubation period of 5-days16.
R0, the basic reproduction number was modelled with a gamma prior distribution using a mean estimate of
2.6 (sd: 2) based on early estimates from Wuhan17,20. Using the EpiEstim R package developed by Cori et
al.21, Rt was estimated from 1000 samples at each time point using parameter specifications as described 17.
As specified by Cori et al.21 the instantaneous reproduction number over time period measured by the
reproduction number is distributed with a gamma distribution, i.e.

Resulting in a posterior mean equal to

And a posterior coefficient of variation (CV, standard deviation divided by mean) equal to

Time varying daily Rt was estimated from the day reported cases exceeded 50 to May 31st, 2020 (Figure 1).
We calculated the average time varying daily Rt for each intervention period as well as the percentage
change in daily Rt from the start to the end of each intervention period. Linear mixed effects modelling fit
by restricted maximum likelihood was used to assess the relationship between the type and timing of
individual NPIs and changes in Rt. We compared the relative percentage reduction in Rt associated with
each NPI and the easing of restrictions by calculating the Œ≤-coefficient estimated marginal mean according
to the following formula:
ùë¶ùëñ = ùõΩ1 ùë•1ùëñ + ùõΩ2 ùë•2ùëñ + ùëè1 ùë¢1ùëñ + ùúÄùëñ

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

where
ùë¶ùëñ is a vector of observations (% change in ùëÖùë° over the intervention period) for country ùëñ
ùë•1ùëñ is the fixed-effect predictor (intervention type), with its regression coefficient ùêµ1
ùë•2ùëñ is the fixed-effect predictor (days since 50th case), with its regression coefficient ùêµ2
ùë¢1 is the random-effect predictor (country), with its regression coefficient ùëè1
ùúÄùëñ is the error for observation in country ùëñ
All calculations and modelling estimations were run in R Studio using R Version 6.3.2.
Results
Global implementation of SARS-CoV-2 related NPIs
After the exclusion of all overlapping interventions, the final analysis consisted of 145 events from 26
countries and 34 US states (Figure 1). In the majority of scenarios, quarantine and isolation, limits on
gatherings and school closures preceded the implementation of household restrictions (Figures 1 and 2).
Universal facemask policies and mandatory quarantine isolation orders were often implemented in
conjunction with other interventions and as a result we were only able to evaluate the impact of these
interventions in 16% (N=10) and 33% (N = 21) of countries and states respectively (Table 1, Figure 1).
There was large variation in the timing of the implementation of NPIs across regions (Figure 1). In Europe,
where incidence has decreased in the majority of countries, 92% of countries (N = 11) have begun to ease
restrictions as of May 31st 2020. Comparatively, restrictions were still in place in African and South & Latin
American countries where incidence is still rising. This same pattern was not observed in the United States
where 71% (N = 27) of states included had begun to ease restrictions irrespective of marked decreases in
incidence (Figure 1).
Table 1: Global coverage of the implementation and easing of Covid-19 related NPIs as of May 31st, 2020
Africa

Middle East

Asia

Europe

(N=3)

(N=3)

(N=3)
3 (100% )
1 (33% )
2 (67% )
(0% )
2 (67% )
2 (67% )

N countries/ states implementing (% regional total)
Quarantine isolation
3 (100% )
2 (67% )
Limits on gatherings
3 (100% )
2 (67% )
School closures
3 (100% )
3 (100% )
Universal mask policies
2 (67% )
(0% )
Household confinement
2 (67% )
1 (33% )
Easing of restrictions
1 (33% )
2 (67% )

(N=12)

South/Latin
America
(N=5)

United States
of America
(N=38)

Global
(N=64)

6 (50% )
11 (92% )
12 (100% )
3 (25% )
12 (100% )
11 (92% )

3 (60% )
3 (60% )
5 (100% )
2 (40% )
4 (80% )
2 (40% )

4 (11% )
24 (63% )
35 (92% )
3 (8% )
31 (82% )
27 (71% )

21 (33% )
44 (69% )
60 (94% )
10 (16% )
52 (81% )
45 (70% )

Figure 1 (below): Timeline of daily reported COVID-19 incidence and implementation of non-pharmaceutical
interventions across different countries (A) and US states (B). Plots are arranged by order of highest cumulative
caseload as of May 31st, 2020 and illustrate the timeline of the implementation of quarantine and isolation policies
(orange), limits on gatherings (yellow), school closures (green) and universal facemask policies (blue). We excluded
other interventions implemented during time-periods of household confinement (red) and specified the date of easing
of restrictions (grey) as defined in the methods. NPI timelines are illustrated alongside daily reported cases (grey bars)
and the estimated daily Rt (blue line and ribbon representing median Rt and 0.05 ‚Äì 0.95 quantiles respectively).

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Relative timing and effect of individual SARS-CoV-2 related NPIs
It was evident that NPIs clustered over time (Figure 2). We observed a negative correlation between mean
daily Rt and relative change in Rt over time, with higher mean Rt and a larger relative reduction in Rt
observed during NPIs implemented in the earlier months of the pandemic (Figure 2, A+B). We estimated
overall reductions in Rt associated with household confinement (23%), limits on social gatherings (10%),
school closures (12%) and mask policies (17%) (Table 2, Figure 2C). In cases where restrictions had been
eased, we estimated a range of impacts on transmission with Rt both increasing and decreasing (Table 2).
We additionally estimated an overall 12% (95% CI: 9-15%) reduction in daily Rt over time, irrespective of
intervention implemented (Table 2). We were unable to estimate plausible estimates for country, state or
regional effect sizes of the individual and overall impact NPIs.
Table 2: Estimated marginal means of % reduction in Rt
Reduction in Rt [95% CI]
Restrictions
Household confinement
Quarantine isolation
Limits on gatherings
School closure
Mask policy
Restrictions eased

23% [18% ; 27%]
8% [-4% ; 20%]
10% [1% ; 18%]
12% [5% ; 19%]
17% [6% ; 28%]
2% -[8% ; 12%]

Figure 2: Timing and relative effect of SARS-CoV-2 related NPIs. We evaluated the median daily Rt (A) and
overall change in daily Rt (B) associated with quarantine and isolation of known positives (orange), limits on
gatherings (yellow), school closures (green) and universal facemask policies (blue), household confinement (red) and
easing of restrictions (grey) over time. Dots represent the start date of each intervention and easing of restrictions
with T=0 defined as the day since cases exceeded 50. We estimated the overall relative % in R t associated with each
intervention (C) with black lines representing the interquartile range and dots representing outlier events.

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

In line with previous modelling studies8,9, we found that household confinement was associated with the
largest reduction in Rt. .In a time independent analysis, all other NPIs were associated with a higher Rt in
comparison to household confinement as a baseline intervention (Table 3A). When adjusting for the
combined impact of all NPIs (ie. the average change in Rt over time), the range of impact sizes for other
NPIs widened and in all cases included zero (Table 3B), supporting the effect of time evident in the first
step of our analysis (Figure 2A and B).
Table 3: Beta-coefficient impact estimates of % change in Rt associated with other NPIs, easing of restrictions
and overall change in Rt overtime compared to household confinement

Intervention
Quarantine isolation
Limits on gatherings
School closure
Mask policy
Easing of restrictions
Change in Rt over time

Beta-coefficient estimate [95% CI]*
Time independent A
Time dependent B
0,16 [0,03 ; 0,28]
0,10 [0,02 ; 0,19]
0,08 [0,00 ; 0,15]
0,09 [-0,02 ; 0,21]
0,30 [0,23 ; 0,38]
-

0,15 [0,02 ; 0,27]
0,13 [0,04 ; 0,22]
0,10 [0,03 ; 0,18]
0,06 [-0,06 ; 0,18]
0,21 [0,09 ; 0,33]
0,002 [0,00 ; 0,05]

* Positive coefficients indicate an associated larger Rt in comparison to household confinement
A
Linear mixed effects model including only fixed effects of NPIs and easing of restrictions
B
Linear mixed effects model including fixed effects of NPIs, easing of restrictions and change in Rt over time

Discussion
We evaluated the impact of specific NPIs on reported SARS-CoV-2 infection rates in a global context. We
found a large variation in the timing and combination of NPIs implemented across all global regions. In 26
countries and 34 US States, we estimated a 23%, 17%, 12% and 10% reduction in the daily time varying
Rt as a result of household confinement, mask policies, school closures and limits on social gatherings
respectively. In agreement with current SARS-CoV-2 observational evidence11 and data from a recent
systematic review4, we found that earlier implementation of NPIs had a larger impact on the reduction of
Rt.. We additionally estimated an overall 12% reduction in Rt in all contexts where NPIs had been
implemented. The easing of restrictions had a heterogeneous effect, owing in part to restrictions being eased
in groups, making it harder to delineate the effect of lifting each NPI in turn
Globally, the majority of countries have implemented some type of NPI and we hypothesize that all have
experienced large-scale behaviour changes as a result of the SARS-CoV-2 pandemic. As such we do not
have a suitable counterfactual scenarios to estimate rates of infection in the total absence of NPIs.
The overall 12% reduction in Rt, over time may be representative of the overall impact of sequential
interventions and general changes in behaviour 'snowballing' as global awareness increased, resulting in
the overall reduction in Rt regardless of the type and order of interventions implemented. In line with
assumptions informed by other studies4,8 and expert opinions9, we found that in the absence of any other
NPI, household confinement has the largest impact on reduction in Rt. In almost all cases, additional NPIs
were implemented prior to household confinements and as such, residual effects from these interventions
may contribute to strong reductions observed.
We were able to estimate plausible associated reductions for the above-mentioned NPIs and found a large
variation in the impact of quarantine and isolation and easing of restrictions. We reported an overall 23%
(95% CI: 18-27%) reduction in Rt as a result of home confinements in comparison to the 81% (95% CI: 7587%) estimated by Flaxman et al.8 The study by Flaxman et al included 11 European countries8, those first
affected by the pandemic where the majority had reached epidemic control by the end of May 2020 7. Our
estimate of the impact was informed by the same countries as well as countries affected later on the global
trajectory that have not yet reached a peak of infections and thus observed smaller reductions in R t during

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

intervention periods. Due to the large variation in impacts observed, we were unable to ascertain region and
country level specific effects to further investigate this relationship.
Current observational estimates of the potential impact of NPIs on SARS-CoV-2 are based on historical
interventions to control SARS and MERS outbreaks3,4 and the impact of NPI measured by real-time SARSCoV-2 reports13. While observational evidence supports the implementation of NPIs, estimates using
reported SARS-CoV-2 incidence are limited by a number of factors discussed later on. As such, dynamic
mathematical models with country specific demographics and infection parameters have been used to
estimate the individual impacts of NPIs on SARS-CoV-2 in China6,22, the UK23 and in Europe 7‚Äì10. Using
a mathematical model informed by region-specific smartphone mobility data, Lai et al. estimated the role
of local travel restrictions, identification and isolation of cases and social distancing measures in curbing
SARS-CoV-2 infection rates in China6. With a detailed timeline of region specific NPI implementations
and by estimating population mobility, region-specific contact patterns and resultant SARS-CoV-2
infection rates, authors concluded that lockdown alone would not have resulted in controlling infection in
Wuhan if not preceded by local travel restrictions6. They additionally noted the importance of the timing of
interventions, estimating that the implementation of NPIs a week earlier or later may have resulted in 3fold reduction or increase in observed cases respectively6. Flaxman et al. evaluated the impacts of NPIs in
11 European countries, accounting for the lag in case reporting by back estimating Rt from reported death
rates8. Due to the rapid succession of the implementation of NPIs during the beginning of the epidemic,
they were unable to estimate the individual impact of NPIs with the exception of lockdown measures.
Our analysis had a number of limitations. Firstly, our metric of comparison, the time varying Rt based on
reported cases, is sensitive to country level differences in testing coverage and strategies. In single country
studies, it has been difficult to accurately estimate true infection rates and Rt due to the large number of
asymptomatic infections that are assumed to go unreported24. Daily-confirmed cases do not give an accurate
depiction of the total infected population at a given point in time. Country and region-specific delays in
testing, in addition to differential delays between the reporting of positive and negative cases, result in a
lag between daily reported cases and the actual burden of infection. A combination of rapidly evolving
testing recommendations25,26, variations in laboratory processing capacities and, reagent shortages have
resulted in the implementation of a number of different testing strategies across countries and over time. It
is uncertain whether mass testing, shown to successful in the case of South Korea27, is feasible in other
contexts, and modelling studies indicate that in the absence of contact tracing, widespread testing will not
be sufficient in containing infection rates27,28.
Secondly, this study was limited by the epidemiological complexity of ascertaining the impacts of
individual COVID-19 NPIs implemented thus far. NPIs have been implemented with overlapping
timeframes, at varying levels of severity and have been adhered to with differing levels of compliance, even
within the same country. In order to account for this, we evaluated only interventions that had been
implemented in absence of any other intervention for a minimum period of five days. This criterion was
based on the conservative assumption of a 5-day latency period for SARS-CoV-2, although reports estimate
that an individual may be infectious for anywhere from 3-14 days16. Based on this, it may take up to two
weeks to observe the impact of any given intervention (or even longer taking reporting delays into account),
and therefore it is difficult to disentangle the immediate effect of an intervention and the residual impact of
an intervention implemented previously. In order to account for this and the above-mentioned limitations
of reported case data, we used a Bayesian methodology to model Rt with uncertainty in time to symptoms
onset, reporting delays and a range of estimates for the serial interval and generation time based on currently
available reports. These relationships are further confounded by static population-specific factors such as
age distributions, population density and distribution of underlying comorbidities that would contribute to
a differential rate of infections between countries. In addition to time-varying factors such as changes in
population mobility and case-importation rates that are not well documented, interventions themselves were
implemented at different time points in the global trajectory of the pandemic.

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

In agreement with what has been previously published4,7‚Äì11, we find that the implementation of nonpharmaceutical interventions (NPIs) has been effective in reducing the acceleration of the COVID-19
pandemic on a global level and that earlier implementation of NPIs results in stronger reduction in
transmission. In comparison to studies based in European countries, we estimate a more conservative
overall impact of lockdown measures, likely driven by the inclusion of additional countries affected later
in the global trajectory of the epidemic. We find that this effect remains after controlling for time since first
100 infections. At this early stage we have been unable to quantify the impact of easing of SARS-CoV-2
restrictions or determine whether NPI implementation will result in epidemic control in countries where
cases are still rising. There is a need for continual assessment of the efficacy and optimal combination of
individual NPIs as more data become available.
References:
1.

European Centre for Disease Prevention and Control. Geographic distribution of Covid-19 cases
worldwide. Acessed May 31st 2020, available online at:
https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distributioncovid-19-cases-worldwide (2020)

2.

World Health Organization. Modes of transmission of virus causing COVID-19: implications for
IPC precaution recommendations: scientific brief, 29 March 2020. World Health
Organization. https://apps.who.int/iris/handle/10665/331616 (2020)

3.

Ahmed, F., Zviedrite, N. & Uzicanin, A. Effectiveness of workplace social distancing measures in
reducing influenza transmission: A systematic review. BMC Public Health 18, 1‚Äì13 (2018).

4.

Schmidt, B., Davids, E. & Malinga, T. Quarantine alone or in combination with other public
health measures to control COVID-19: a rapid review. South African Med. J. 110, (2020).

5.

Cowling, Benjamin J., Sheikh Taslim Ali, Tiffany WY Ng, Tim K. Tsang, Julian CM Li, et al.
"Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong
Kong: an observational study." MedRxiv (2020).

6.

Lai, Shengjie, Nick W. Ruktanonchai, Liangcai Zhou, Olivia Prosper, Wei Luo et al. "Effect of
non-pharmaceutical interventions for containing the COVID-19 outbreak in China." medRxiv
(2020).

7.

Ferguson, Neil, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, et al.
"Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and
healthcare demand." Imperial College London 10 (2020): 77482.

8.

Flaxman, Seth, Swapnil Mishra, Axel Gandy, H. Unwin, Helen Coupland, et al. "Report 13:
Estimating the number of infections and the impact of non-pharmaceutical interventions on
COVID-19 in 11 European countries." (2020).

9.

European Centre of Disease Prevention and Control. ECDC Surveillance Report: Projected
baselines of COVID-19 in the EU / EEA and the UK for assessing the impact of de-escalation of
measures. (2020).

10.

Chen, Xiaohui, and Ziyi Qiu. "Scenario analysis of non-pharmaceutical interventions on global
COVID-19 transmissions." arXiv preprint arXiv:2004.04529 (2020).

11.

Islam, Nazrul, Stephen J. Sharp, Gerardo Chowell, Sharmin Shabnam, Ichiro Kawachi, et al.
"Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment
in 149 countries." bmj 370 (2020).

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

12.

IEA. Global Energy Review 2020. (2020).

13.

WHO (World Health Organization). Tracking Public Health and Social Measures (PHSMs).
Accessed may 31st 2020, available at: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/phsm. (2020)

14.

Centers for Disease Control and Prevention. Centres for Disease Control COVID-19 Case
Surveillance Public Use Data. 2020. (2020).

15.

Boston University School of Public Health. COVID-19 US state policy database. (2020).
Accessed: 31st May 2020, Available at: https://www.bu.edu/sph/2020/04/01/tracking-covid-19policies/. (2020)

16.

Lauer, Stephen A., Kyra H. Grantz, Qifang Bi, Forrest K. Jones, Qulu Zheng, et al. "The
incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed
cases: estimation and application." Annals of internal medicine 172, no. 9 (2020): 577-582.

17.

Abbott, Sam, Joel Hellewell, Robin N. Thompson, Katharine Sherratt, Hamish P. Gibbs, et al.
"Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational
case counts." Wellcome Open Research 5, no. 112 (2020): 112.

18.

Moritz Kraemer, David Pigott, Bo Xu, Sarah Hill, Bernardo Gutierrez et al. Epidemiological Data
from the nCoV-2019 Outbreak_ Early Descriptions from Publicly Available Data. (2020).
Available at: https://virological.org/t/epidemiological-data-from-the-ncov-2019-outbreak-earlydescriptions-from-publicly-available-data/337 . (Accessed: 31st May 2020)

19.

Ganyani, Tapiwa, C√©cile Kremer, Dongxuan Chen, Andrea Torneri, Christel Faes, Jacco Wallinga,
and Niel Hens. "Estimating the generation interval for coronavirus disease (COVID-19) based on
symptom onset data, March 2020." Eurosurveillance 25, no. 17 (2020): 2000257.

20.

Imai, Natsuko, Anne Cori, Ilaria Dorigatti, Marc Baguelin, Christl A. Donnelly, Steven Riley, and
Neil M. Ferguson. "Report 3: transmissibility of 2019-nCoV." Imperial College London (2020).

21.

Cori, Anne, Neil M. Ferguson, Christophe Fraser, and Simon Cauchemez. "A new framework and
software to estimate time-varying reproduction numbers during epidemics." American journal of
epidemiology 178, no. 9 (2013): 1505-1512.

22.

Prem, Kiesha, Yang Liu, Timothy W. Russell, Adam J. Kucharski, Rosalind M. Eggo, Nicholas
Davies, Stefan Flasche et al. "The effect of control strategies to reduce social mixing on outcomes
of the COVID-19 epidemic in Wuhan, China: a modelling study." The Lancet Public
Health (2020).

23.

Hellewell, Joel, Sam Abbott, Amy Gimma, Nikos I. Bosse, Christopher I. Jarvis, Timothy W.
Russell, James D. Munday et al. "Feasibility of controlling COVID-19 outbreaks by isolation of
cases and contacts." The Lancet Global Health (2020).

24.

Oran, Daniel P., and Eric J. Topol. "Prevalence of Asymptomatic SARS-CoV-2 Infection: A
Narrative Review." Annals of Internal Medicine (2020).

25.

Patel, Robin, Esther Babady, Elitza S. Theel, Gregory A. Storch, Benjamin A. Pinsky, et al.
"Report from the American Society for Microbiology COVID-19 international summit, 23 march
2020: value of diagnostic testing for SARS‚ÄìCoV-2/COVID-19." (2020).

26.

Hale, Thomas, Anna Petherick, Toby Phillips, and Samuel Webster. "Variation in government
responses to COVID-19." Blavatnik school of government working paper 31 (2020).

medRxiv preprint doi: https://doi.org/10.1101/2020.07.30.20164939; this version posted August 5, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

27.

Balilla, Jeffhraim. "Assessment of COVID-19 mass testing: the case of South Korea." Available at
SSRN 3556346 (2020).

28.

Salath√©, Marcel, Christian L. Althaus, Richard Neher, Silvia Stringhini, Emma Hodcroft, et al.
"COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and
isolation." Swiss medical weekly 150, no. 11-12 (2020): w20225.

